NCRP

1991 Program

Program of the 1991 Annual Meeting, Genes, Cancer and Radiation Protection

April 3-4, 1991

Introduction
Mortimer L. Mendelsohn, Chair

Radiation Induced Cancer Risk Estimation, Today and Tomorrow
Warren K. Sinclair, NCRP

Carcinogenesis: Overview
Michael N. Gould, University of Wisconsin

Radiation Mechanisms (Damage, Repair and Mutagenesis)
S. James Adelstein, Chair

Radiation Tracks in Biological Material: Initial Damage in Cells, DNA and Associated Structures
Dudley Goodhead, Medical Research Council, United Kingdom

The Intracellular Molecular Damage Which is Dependent on Radiation Energy Deposition Patterns at the Nanometer Level
John Ward, University of California, San Diego

Genetic Regulation of Base Damage and Double Strand Break in Human Cells and Associated Human Genetic Disorders
James Cleaver, University of California, San Francisco

Molecular Characterization of Radiation Induced Specific Locus Mutations In Vitro
Amy Kronenberg, Lawrence Livermore National Laboratory

Genetic Aspects of Carcinogenesis
R.J. Michael Fry, Chair

Clonal Chromosome Aberrations in Human Leukemia: Markers of Mutagenic Exposure
Janet D. Rowley, University of Chicago

The Role of Tumor Suppressor Genes in Second Malignancies
Stephen Friend, Massachusetts General Cancer Center

The Genetic Changes on Ras Oncogenes in Radiation Induced Lymphomas
Angel Pellicer, New York University School of Medicine

Biological Dosimetry
Michael A. Bender, Chair

Applications of Molecular Cytogenetic Techniques in Radiation Dosimetry
Joe Gray, Lawrence Livermore National Laboratory

Somatic Gene Mutation in the Human in Relation to Radiation Risk
Mortimer L. Mendelsohn, Lawrence Livermore National Laboratory

Fifteenth Lauriston S. Taylor Lecture on Radiation Protection and Measurements
Introduction of the Lecturer, Charles B. Meinhold
When is a Dose Not a Dose?, Victor P. Bond

Epidemiology
Arthur C. Upton, Chair

Epidemiological Applications
Fred Li, National Cancer Institute, Dana Farber Cancer Center

Altered Proto-oncogenes and Tumor Suppressor Genes in “Normal” Tissues of People Exposed to Radium
Eliezer Huberman, Argonne National Laboratory

Conclusion
Mortimer L. Mendelsohn, Chair

Risky Genes, What do they Mean?
John D. Boice, Jr., National Cancer Institute

Back to Top
Last modified: June 2, 2015